리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 10월
페이지 정보:영문 96 Pages
라이선스 & 가격 (부가세 별도)
한글목차
칸나비디올 시장은 2030년까지 212억 달러에 이를 전망입니다.
2023년에 81억 달러로 추정된 칸나비디올 시장은 예측 기간 동안 복합 연간 성장률(CAGR) 14.6%로 성장할 전망이며 2030년에는 212억 달러에 이를 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 Hump는 복합 연간 성장률(CAGR) 15.9%로 성장을 지속하고, 분석 기간이 끝날 때 143억 달러에 이를 것으로 예상됩니다. 마리화나 분야의 성장률은 분석 기간 동안 복합 연간 성장률(CAGR) 12.4%로 추정됩니다.
미국 시장은 21억 달러로 추정되며 중국은 복합 연간 성장률(CAGR) 19.5%로 성장할 것으로 예측됩니다.
미국 칸나비디올 시장은 2023년 21억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 54억 달러 규모에 이를 것으로 예측되며, 예측 기간 동안 복합 연간 성장률(CAGR)은 19.5%입니다. 다른 주목할만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 복합 연간 성장률(CAGR)은 각각 10.4%와 12.8%로 예측되고 있습니다. 유럽에서는 독일이 복합 연간 성장률(CAGR) 11.9%로 성장할 것으로 예측됩니다.
세계의 칸나비디올(CBD) 시장- 주요 동향과 촉진요인 정리
칸나비디올(CBD)이 세계적으로 인기를 끌고 있는 이유란?
칸나비디올(CBD)은 특히 만성 통증, 불안, 간질 및 기타 의학적 상태 관리와 같은 광범위한 건강상의 이점과 치료 용도로 전 세계적으로 빠르게 인기를 얻고 있습니다. 대마초의 정신 활성 성분인 테트라하이드로칸나비놀(THC)과 달리 CBD는 '하이'를 일으키지 않기 때문에 대마초와 같은 정신에 작용하지 않고 다양한 질병의 완화를 요구하는 사람들에게 더욱 매력적 선택이되었습니다. 대마 식물에서 유래하는 CBD는 오일, 캡슐, 식용, 크림, 팅크제 등 다양한 형태로 판매되고 있어 다양한 소비자층에 이용하기 쉬워지고 있습니다. CBD의 대두는 자연요법과 대체요법에 대한 소비자의 관심 증가와 칸나비노이드의 잠재적인 건강효과에 대한 의식 증가로 인한 것이 큽니다.
여러 국가에서 의료용 및 오락용 대마초가 널리 합법화됨에 따라 CBD 제품 수요가 더욱 가속화되고 있습니다. 소비자가 식물 유래의 홀리스틱 치료에 점점 눈을 돌리면서 CBD는 스트레스, 염증, 수면장애 및 기타 건강 문제를 완화하려는 사람들에게 선호되는 선택입니다. FDA가 에피디올렉스(간질 치료용 CBD 기반 의약품)를 승인한 것으로 입증된 바와 같이, 간질과 같은 신경 질환을 관리하기 위한 CBD의 가능성에 대한 조사는 그 치료의 가능성 에 신뢰성을 더해 시장의 성장에 박차를 가하고 있습니다.
기술의 발전은 CBD 산업을 어떻게 형성하는가?
CBD의 추출, 제제화, 생산에 있어서의 기술의 진보가 시장을 크게 바꾸고 있습니다. CO2 추출과 같은 보다 효율적인 추출 방법의 개발로 제조업체는 원치 않는 물질을 제거하면서 대마초 식물의 유익한 화합물을 보유하는 보다 순도가 높은 CBD 제품을 생산할 수 있습니다. 이 추출 기술의 향상으로 소비자는 보다 안전하고 안정적이며 강력한 CBD 제품을 얻을 수 있게 되었습니다. 게다가 나노에멀젼 기술의 혁신은 수용성 CBD의 생산을 가능하게 하고, 생물학적 이용능력과 흡수를 향상시키고, CBD 제품이 저용량으로 보다 효과적으로 됩니다.
또 다른 주목할만한 진보는 제품 개발 및 사용자 정의 분야입니다. CBD에 대한 소비자 수요가 계속 증가하고 있는 가운데 제조업체는 특정 소비자의 요구를 목표로 음료부터 스킨 케어 라인까지 다양한 CBD 제품을 생산하고 있습니다. CBD의 선호품, 음료, 퍼스널케어 제품의 등장은 제조업체가 다른 시장에 대응하기 위해 어떻게 혁신하고 있는지를 돋보이게합니다. 또한 검사 및 분석 도구의 진보는 CBD 제품의 안전과 규정을 개선하고 필요한 품질 기준을 충족하는지 확인합니다. 기술이 계속 진화함에 따라 제품의 처방 및 전달 방법에 대한 추가 혁신으로 이어지고 건강과 웰빙에서 CBD의 적용 범위가 넓어질 것입니다.
소비자의 선호 변화는 CBD 시장에 어떤 영향을 미치는가?
소비자의 선호 변화, 특히 자연적이고 건강 지향적인 제품으로의 전환은 CBD 시장 형성에 매우 중요한 역할을 합니다. 오늘날의 소비자는 건강 지향이 강하고 기존의 의약품을 대체하는 자연적인 것을 적극적으로 요구하고 있습니다. CBD는 식물 유래이며 다양한 건강 문제에 대한 자연 요법으로 판매되는 경우가 많기 때문에이 프로파일에 완벽하게 적용됩니다. 셀프 케어와 건강 지향 동향 증가로 CBD 제품은 휴식, 통증 관리, 스킨 케어에 CBD 오일과 크림을 사용하는 등 점점 일상 생활에 도입되고 있습니다. 또한 소비자들이 지속가능성과 건강이라는 가치관에 맞는 제품을 찾고 있기 때문에 클린 라벨, 유기농, 비유전자 재조합 CBD 제품에 대한 수요도 증가하고 있습니다.
또한, 의료 및 웰니스에서 개인화의 추세는 맞춤형 CBD 솔루션에 대한 수요를 촉진하고 있습니다. 소비자는 특정 건강 상태, 라이프 스타일 또는 선호에 맞는 CBD 제품을 찾고 있습니다. 예를 들면, 스트레스 완화나 운동 능력의 회복, 혹은 수면 강화를 위한 CBD가 들어간 제품 등입니다. 개별화된 웰니스 솔루션에 대한 관심이 높아짐에 따라 기업은 제품 라인을 확대하고 이러한 수요에 부응하기 위해 적극적인 마케팅 전략을 세우게 되었습니다. 게다가 더 많은 소비자들이 CBD의 잠재적인 이점에 대한 지식을 깊게 함에 따라 주류 보충제로서 CBD의 수용성이 높아지고 시장 성장을 더욱 촉진하고 있습니다.
칸나비디올(CBD) 시장의 성장은 여러 요인별 견인
칸나비디올(CBD) 시장의 성장은 건강상의 이점에 대한 소비자의 의식 증가, 다양한 지역의 대마초 합법화, 제품 제공 확대 등 여러 요인에 의해 견인되고 있습니다. 더 많은 소비자가 통증 완화, 불안 관리 및 기타 건강 상태를 위해 CBD에 눈을 돌리고 있기 때문에 전통적인 약물을 대체하는 자연적인 것에 대한 수요 증가가 중요한 추진력이되었습니다. 특히 간질, 만성 통증, 염증 등의 증상에 대한 CBD의 치료 가능성을 뒷받침하는 과학적 연구 증가도 CBD 제품의 광범위한 채용을 뒷받침하고 있습니다.
합법화와 규제 변화도 시장 성장을 뒷받침하는 큰 요인입니다. 북미, 유럽, 아시아의 일부에서 CBD의 사용을 규제하는 법률이 완화됨으로써 시장 확대의 새로운 기회가 탄생했습니다. 대마초와 CBD를 합법적으로 입수할 수 있는 국가에서는 소비자가 영양보조식품에서 반려동물용품에 이르기까지 CBD의 잠재적인 용도를 점점 탐구하고 있으며 시장은 급성장하고 있습니다. 게다가 주요 소매 체인이 CBD 시장에 진입했고 온라인 유통 채널도 완성됨에 따라 CBD 제품은 세계 소비자들에게 더욱 친숙해졌습니다. 게다가, 웰빙과 홀리스틱 건강에 대한 관심 증가는 미용 및 퍼스널케어 산업에서의 CBD 사용 증가와 함께 이 분야의 성장에 기여하고 있습니다. 대마초에 대한 스티그마가 계속 엷어지면서 더 많은 소비자가 웰니스와 대체치료를 선호하게 됨에 따라 CBD 시장은 지속적인 성장이 예상되고 신제품의 혁신과 용도 확대가 다양한 산업에 대한 수요 를 견인하고 있습니다.
조사 대상 기업 예(총 47건)
ABcann Medicinals, Inc.
Aphria, Inc
Aurora Cannabis
Canopy Growth Corporation
CBD LION
CBDfxBota
CBDistillery
cbdMD
GW Pharmaceuticals, plc
Kazmira
Maricann, Inc.(Wayland Group Corporation)
Medixcbd
Medterra
NuLeaf Naturals
Organigram Holding, Inc.
The CBD Company
The Cronos Group
Tikun Olam
Tilray
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 촉진요인
시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
스페인
러시아
기타 유럽
아시아태평양
호주
인도
한국
기타 아시아태평양
라틴아메리카
아르헨티나
브라질
멕시코
기타 라틴아메리카
중동
이란
이스라엘
사우디아라비아
아랍에미리트(UAE)
기타 중동
아프리카
제4장 경쟁
BJH
영문 목차
영문목차
Global Cannabidiol Market to Reach US$21.2 Billion by 2030
The global market for Cannabidiol estimated at US$8.1 Billion in the year 2023, is expected to reach US$21.2 Billion by 2030, growing at a CAGR of 14.6% over the analysis period 2023-2030. Hemp, one of the segments analyzed in the report, is expected to record a 15.9% CAGR and reach US$14.3 Billion by the end of the analysis period. Growth in the Marijuana segment is estimated at 12.4% CAGR over the analysis period.
The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 19.5% CAGR
The Cannabidiol market in the U.S. is estimated at US$2.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$5.4 Billion by the year 2030 trailing a CAGR of 19.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.4% and 12.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.9% CAGR.
Global Cannabidiol (CBD) Market – Key Trends & Drivers Summarized
Why Is Cannabidiol (CBD) Gaining Global Popularity?
Cannabidiol (CBD) has rapidly gained popularity across the globe due to its wide range of health benefits and therapeutic applications, particularly in managing chronic pain, anxiety, epilepsy, and other medical conditions. Unlike tetrahydrocannabinol (THC), the psychoactive component of cannabis, CBD does not produce a "high," making it a more appealing option for those seeking relief from various ailments without the mind-altering effects of marijuana. Derived from the cannabis plant, CBD is available in various forms, including oils, capsules, edibles, creams, and tinctures, making it accessible to a diverse consumer base. Its rise is largely driven by increasing consumer interest in natural and alternative treatments, as well as growing awareness about the potential health benefits of cannabinoids.
The widespread legalization of cannabis for medical and recreational use in several countries has further accelerated the demand for CBD products. With consumers increasingly turning to plant-based and holistic remedies, CBD has become a preferred option for those seeking relief from stress, inflammation, sleep disorders, and other health concerns. Research into CBD's potential to manage neurological conditions, such as epilepsy, as evidenced by the FDA's approval of Epidiolex (a CBD-based drug for epilepsy treatment), has added credibility to its therapeutic potential, fueling growth in the global market.
How Are Technological Advancements Shaping the CBD Industry?
Technological advancements in the extraction, formulation, and production of CBD are significantly transforming the market. The development of more efficient extraction methods, such as CO2 extraction, has allowed manufacturers to produce higher-purity CBD products that retain the beneficial compounds of the cannabis plant while eliminating unwanted substances. This improvement in extraction technology ensures that consumers have access to safer, more consistent, and more potent CBD products. Moreover, innovations in nanoemulsion technology are enabling the production of water-soluble CBD, which enhances bioavailability and absorption, making CBD products more effective at lower doses.
Another notable advancement is in the area of product development and customization. As consumer demand for CBD continues to grow, manufacturers are creating a diverse range of CBD-infused products, from beverages to skincare lines, targeting specific consumer needs. The rise of CBD edibles, beverages, and personal care products highlights how manufacturers are innovating to cater to different markets. Additionally, advancements in testing and analytics tools have improved the safety and regulation of CBD products, ensuring that they meet the necessary quality standards. As technology continues to evolve, it will likely lead to further innovations in product formulation and delivery methods, broadening the scope of CBD's application in health and wellness.
How Are Changing Consumer Preferences Influencing the CBD Market?
Changing consumer preferences, particularly the shift toward natural and wellness-oriented products, are playing a pivotal role in shaping the CBD market. Today’s consumers are more health-conscious and are actively seeking out natural alternatives to conventional pharmaceuticals. CBD fits this profile perfectly, as it is derived from plants and is often marketed as a natural remedy for various health issues. The growing trend toward self-care and wellness has seen CBD products increasingly integrated into daily routines, such as using CBD oils or creams for relaxation, pain management, or skin care. The demand for clean-label, organic, and non-GMO CBD products is also on the rise, as consumers seek out products that align with their values of sustainability and health.
Additionally, the trend of personalization in healthcare and wellness is driving the demand for customized CBD solutions. Consumers are looking for CBD products tailored to specific health conditions, lifestyles, or preferences, such as CBD-infused products for stress relief, athletic recovery, or enhanced sleep. This growing interest in personalized wellness solutions has prompted companies to expand their product lines and create targeted marketing strategies to meet these demands. Moreover, as more consumers become educated about the potential benefits of CBD, its acceptance as a mainstream supplement is increasing, further driving market growth.
Growth in the Cannabidiol (CBD) Market Is Driven by Several Factors
The growth in the cannabidiol (CBD) market is driven by several factors, including increasing consumer awareness of its health benefits, the legalization of cannabis in various regions, and the expansion of product offerings. The rising demand for natural alternatives to traditional medications is a significant driver, as more consumers are turning to CBD for pain relief, anxiety management, and other health conditions. The growing body of scientific research supporting the therapeutic potential of CBD, particularly for conditions like epilepsy, chronic pain, and inflammation, is also encouraging wider adoption of CBD products.
Legalization and regulatory changes are another major factor fueling market growth. The relaxation of laws governing the use of CBD in North America, Europe, and parts of Asia has created new opportunities for market expansion. In countries where cannabis and CBD are legally accessible, the market is experiencing rapid growth, with consumers increasingly exploring the potential uses of CBD in everything from dietary supplements to pet products. Additionally, the entry of major retail chains into the CBD market, along with online distribution channels, has made CBD products more accessible to consumers globally. Furthermore, the rising interest in wellness and holistic health, along with the increasing use of CBD in the beauty and personal care industry, is contributing to the sector's growth. As the stigma around cannabis continues to fade and more consumers prioritize wellness and alternative treatments, the CBD market is expected to see sustained growth, with new product innovations and expanded applications driving demand across a variety of industries.
Select Competitors (Total 47 Featured) -
ABcann Medicinals, Inc.
Aphria, Inc
Aurora Cannabis
Canopy Growth Corporation
CBD LION
CBDfxBota
CBDistillery
cbdMD
GW Pharmaceuticals, plc
Kazmira
Maricann, Inc. (Wayland Group Corporation)
Medixcbd
Medterra
NuLeaf Naturals
Organigram Holding, Inc.
The CBD Company
The Cronos Group
Tikun Olam
Tilray
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Cannabidiol - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Evolution of Global Legalization and Regulatory Frameworks Dramatically Expands Market Opportunities for Cannabidiol (CBD) Products
Surging Consumer Interest and Increased Public Awareness Propel the Demand for CBD in Health and Wellness Applications
Significant Advancements in Clinical Research Highlight the Therapeutic Potential of CBD, Broadening its Use in Medical Treatments
Expansion of Retail Distribution Channels Enhances Consumer Accessibility and Spurs Growth in the CBD Market
Technological Innovations in CBD Extraction and Purification Processes Enhance Product Quality and Consumer Trust
Increasing Adoption of CBD-Based Products Among the Elderly Population Strengthens Market Penetration and Reach
Integration of CBD into Cosmetics and Personal Care Lines Opens New Avenues in the Fast-Growing Beauty Industry
Rising Global Pet Ownership and the Growing Acceptance of CBD for Pet Health and Wellness Drive Product Line Diversification
Growing Endorsements from Athletes and Integration of CBD in Sports Recovery Products Propel Market Visibility and Acceptance
Enhanced Consumer Focus on Natural and Organic Ingredients Amplifies the Business Case for CBD in the Nutraceutical Sector
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for B2C by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for B2C by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for B2C by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for B2B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for B2B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for B2B by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Medical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Personal Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Personal Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Personal Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Wellness by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Wellness by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Wellness by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 19: World Cannabidiol Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
TABLE 20: World Recent Past, Current & Future Analysis for Cannabidiol by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Cannabidiol by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Cannabidiol by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 23: World Recent Past, Current & Future Analysis for Hemp by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 24: World Historic Review for Hemp by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 25: World 16-Year Perspective for Hemp by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 27: World Historic Review for Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 28: World 16-Year Perspective for Marijuana by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 29: USA Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 30: USA Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 31: USA 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 32: USA Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 33: USA Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 34: USA 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 35: USA Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 36: USA Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 37: USA 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
CANADA
TABLE 38: Canada Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 40: Canada 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 41: Canada Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 42: Canada Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 43: Canada 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 44: Canada Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 46: Canada 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
JAPAN
Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 47: Japan Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 48: Japan Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 49: Japan 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 50: Japan Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 51: Japan Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 52: Japan 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 53: Japan Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 55: Japan 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
CHINA
Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 56: China Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 57: China Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 58: China 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 59: China Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 60: China Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 61: China 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 62: China Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 63: China Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 64: China 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
EUROPE
Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 65: Europe Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 66: Europe Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 67: Europe 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 68: Europe Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 69: Europe Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 70: Europe 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 71: Europe Recent Past, Current & Future Analysis for Cannabidiol by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 72: Europe Historic Review for Cannabidiol by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 73: Europe 16-Year Perspective for Cannabidiol by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 74: Europe Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 76: Europe 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
FRANCE
Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 77: France Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 78: France Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 79: France 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 80: France Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 81: France Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 82: France 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 83: France Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 84: France Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 85: France 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
GERMANY
Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 86: Germany Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 87: Germany Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 88: Germany 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 89: Germany Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 90: Germany Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 91: Germany 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 92: Germany Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 93: Germany Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 94: Germany 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
ITALY
TABLE 95: Italy Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 96: Italy Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 97: Italy 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 98: Italy Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 99: Italy Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 100: Italy 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 101: Italy Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 102: Italy Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 103: Italy 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
UNITED KINGDOM
Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 104: UK Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 105: UK Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 106: UK 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 107: UK Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 108: UK Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 109: UK 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 110: UK Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 111: UK Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 112: UK 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
SPAIN
TABLE 113: Spain Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 114: Spain Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 115: Spain 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 116: Spain Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 117: Spain Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 118: Spain 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 119: Spain Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 120: Spain Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 121: Spain 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
RUSSIA
TABLE 122: Russia Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 123: Russia Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 124: Russia 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 125: Russia Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 126: Russia Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 127: Russia 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 128: Russia Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 129: Russia Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 130: Russia 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 132: Rest of Europe Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 133: Rest of Europe 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 135: Rest of Europe Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 136: Rest of Europe 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 138: Rest of Europe Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 139: Rest of Europe 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 141: Asia-Pacific Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 142: Asia-Pacific 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 144: Asia-Pacific Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 145: Asia-Pacific 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Cannabidiol by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 147: Asia-Pacific Historic Review for Cannabidiol by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 148: Asia-Pacific 16-Year Perspective for Cannabidiol by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 150: Asia-Pacific Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 151: Asia-Pacific 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
AUSTRALIA
Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 152: Australia Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 153: Australia Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 154: Australia 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 155: Australia Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 156: Australia Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 157: Australia 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 158: Australia Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 159: Australia Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 160: Australia 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
INDIA
Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 161: India Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 162: India Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 163: India 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 164: India Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 165: India Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 166: India 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 167: India Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 168: India Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 169: India 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 170: South Korea Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 171: South Korea Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 172: South Korea 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 173: South Korea Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 174: South Korea Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 175: South Korea 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 176: South Korea Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 177: South Korea Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 178: South Korea 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 180: Rest of Asia-Pacific Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 183: Rest of Asia-Pacific Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 186: Rest of Asia-Pacific Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
LATIN AMERICA
Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 188: Latin America Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 189: Latin America Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 190: Latin America 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 191: Latin America Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 192: Latin America Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 193: Latin America 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 194: Latin America Recent Past, Current & Future Analysis for Cannabidiol by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 195: Latin America Historic Review for Cannabidiol by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 196: Latin America 16-Year Perspective for Cannabidiol by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 197: Latin America Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 198: Latin America Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 199: Latin America 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 200: Argentina Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 201: Argentina Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 202: Argentina 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 203: Argentina Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 204: Argentina Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 205: Argentina 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 206: Argentina Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 207: Argentina Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 208: Argentina 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
BRAZIL
TABLE 209: Brazil Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 210: Brazil Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 211: Brazil 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 212: Brazil Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 213: Brazil Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 214: Brazil 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 215: Brazil Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 216: Brazil Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 217: Brazil 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
MEXICO
TABLE 218: Mexico Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 219: Mexico Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 220: Mexico 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 221: Mexico Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 222: Mexico Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 223: Mexico 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 224: Mexico Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 225: Mexico Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 226: Mexico 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 228: Rest of Latin America Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 229: Rest of Latin America 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 231: Rest of Latin America Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 232: Rest of Latin America 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 234: Rest of Latin America Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 235: Rest of Latin America 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
MIDDLE EAST
Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 236: Middle East Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 237: Middle East Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 238: Middle East 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 239: Middle East Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 240: Middle East Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 241: Middle East 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 242: Middle East Recent Past, Current & Future Analysis for Cannabidiol by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
TABLE 243: Middle East Historic Review for Cannabidiol by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 244: Middle East 16-Year Perspective for Cannabidiol by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 245: Middle East Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 246: Middle East Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 247: Middle East 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
IRAN
TABLE 248: Iran Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 249: Iran Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 250: Iran 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 251: Iran Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 252: Iran Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 253: Iran 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 254: Iran Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 255: Iran Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 256: Iran 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
ISRAEL
TABLE 257: Israel Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 258: Israel Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 259: Israel 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 260: Israel Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 261: Israel Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 262: Israel 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 263: Israel Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 264: Israel Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 265: Israel 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 267: Saudi Arabia Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 268: Saudi Arabia 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 270: Saudi Arabia Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 271: Saudi Arabia 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 273: Saudi Arabia Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 274: Saudi Arabia 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 275: UAE Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 276: UAE Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 277: UAE 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 278: UAE Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 279: UAE Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 280: UAE 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 281: UAE Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 282: UAE Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 283: UAE 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 285: Rest of Middle East Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 286: Rest of Middle East 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 288: Rest of Middle East Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 289: Rest of Middle East 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 291: Rest of Middle East Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 292: Rest of Middle East 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030
AFRICA
Cannabidiol Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 293: Africa Recent Past, Current & Future Analysis for Cannabidiol by Distribution Channel - B2B and B2C - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 294: Africa Historic Review for Cannabidiol by Distribution Channel - B2B and B2C Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 295: Africa 16-Year Perspective for Cannabidiol by Distribution Channel - Percentage Breakdown of Value Sales for B2B and B2C for the Years 2014, 2024 & 2030
TABLE 296: Africa Recent Past, Current & Future Analysis for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 297: Africa Historic Review for Cannabidiol by End-Use - Medical, Personal Use, Pharmaceuticals and Wellness Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 298: Africa 16-Year Perspective for Cannabidiol by End-Use - Percentage Breakdown of Value Sales for Medical, Personal Use, Pharmaceuticals and Wellness for the Years 2014, 2024 & 2030
TABLE 299: Africa Recent Past, Current & Future Analysis for Cannabidiol by Source - Hemp and Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
TABLE 300: Africa Historic Review for Cannabidiol by Source - Hemp and Marijuana Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
TABLE 301: Africa 16-Year Perspective for Cannabidiol by Source - Percentage Breakdown of Value Sales for Hemp and Marijuana for the Years 2014, 2024 & 2030